Google-backed 23andMe puts gene tech to work in drug discovery
Google-backed gene testing firm 23andMe is creating a therapeutics group, headed by ex-Genentech veteran Richard Scheller.
Archives for March 18, 2015
Thermo licenses CRISPR tech from ToolGen
Thermo Fisher Scientific has licensed CRISPR/Cas9 intellectual property from ToolGen, a Korean biotech focused on genome editing.
DNA ‘Lego’ to accelerate biodrug production say scientists
A new technique for creating DNA constructs will accelerate development of bacterial strains for drug production say UK scientists.